Communiqués Alkem Laboratories Limited Bombay S.E.

Actions

Marché Fermé - Bombay S.E. 12:02:32 22/09/2026			Varia. 5j.	Varia. 1 janv.
5 337,15 ^INR	-0,24 %		+4,87 %	-3,05 %

16/09	Alkem Laboratories Limited lance NeuCeno (cénobamate) pour le traitement des crises d'épilepsie à début focal chez l'adulte	CI
15/09	Alkem Laboratories Limited annonce la nomination de Shubhadeep Sinha à un poste de direction, effective au 15 septembre 2026	CI

09/02	Protection Of Alphabetic And Abbreviated Marks Under Indian Trademark Law: A Study Of The 'A TO Z' Medicine Case	AQ
19/09/24	Legal Insights On Pharma Trademark Similarity And Confusion	AQ
23/08/24	Exactech and Alkem MedTech form partnership to begin distribution of knee and hip replacement technology in India	AQ
23/08/24	Exactech Enters Landmark Agreement with Alkem MedTech Pvt Ltd for Manufacturing and Marketing Knee and Hip Replacement Implants in India	AQ
10/03/23	Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India	AQ